SCHEMBL3982964

SCHEMBL3982964

N#Cc1c(OC(=O)c2ccccc2)ccc(C(=O)OC(=O)c2occ(-c3ccccc3)c2-c2ccccc2)c1C(=O)NN

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.34
ALDH1A1 P00352 6/20 0.34
KDM4E B2RXH2 6/20 0.34
MAPT P10636 5/20 0.34
HTT P42858 4/20 0.34
HSD17B10 Q99714 3/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
MEN1 O00255 2/20 0.34
GAA P10253 3/20 0.34
TSHR P16473 3/20 0.33
MAPK1 P28482 2/20 0.33
USP2 O75604 2/20 0.33
ALOX15 P16050 1/20 0.33
RECQL P46063 1/20 0.33
LMNA P02545 3/20 0.32
NPSR1 Q6W5P4 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
GBA1 P04062 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973500 0.91 ALDH1A1 (0.36) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3979544 0.90 HPGD (0.41) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3976679 0.89 ALDH1A1 (0.34) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3977141 0.89 ALDH1A1 (0.34) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3975937 0.87 ALDH1A1 (0.36) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3977604 0.82 ALDH1A1 (0.33) HPGDALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL3979485 0.81 MAPT (0.41) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3974632 0.80 CTSD (0.38) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3977002 0.79 POLB (0.37) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL3981614 0.79 ALOX15 (0.34) HPGDALDH1A1KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 HPGD 299/4885ALDH1A1 1389/4885KDM4E 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.